Aarti Pharmalabs Ltd.

₹829.65

-37.4 (-4.3%)

AARTIPHARM Share Price

Pharmaceuticals & Biotechnology

As on September 9, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 7,862 Cr

P/E Ratio44.99

Dividend Yield0.08 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	857.24	Bearish
10-DMA	851.83	Bearish
20-DMA	848.73	Bearish
50-DMA	765.32	Bullish
100-DMA	727.51	Bullish
200-DMA	721.82	Bullish

Historical Performance

1 Year

-8.5%

3 Years

84.3%

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	18,194	21,151	18,526	19,452	11,999
Total Expenditure	14,502	16,507	14,666	16,032	9,947
Other Income	97	101	49	23	42
Operating Profit	3,790	4,745	3,909	3,444	2,095
Interest	469	269	172	211	120
Depreciation	1,043	869	732	625	421
Profit Before Tax	2,329	3,607	3,005	2,608	1,554
Consolidated Net Profit	1,747	2,724	2,169	1,935	1,223
Adjusted EPS	19	30	24	21	4,890

Compounded Sales Growth

10 Years:N/A

5 Years:N/A

3 Years:-1.3

TTM:-3

Compounded Profit Growth

10 Years:566.6

5 Years:566.6

3 Years:-2

TTM:-8.5

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:22.6

TTM:-7.9

Return on Equity

10 Years:N/A

5 Years:4890

3 Years:23.9

last year:19.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	453	453	453	453	2
Total Reserves	20,762	19,429	17,115	15,132	13,409
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	4,195	2,594	1,307	849	728
Other Current Liabilities	1,349	696	458	383	119
Short Term Borrowings	4,569	2,928	2,639	2,138	3,377
Total Liabilities	34,817	29,024	25,821	22,440	20,399
Capital Work in Progress	3,052	3,066	785	622	1,652
Long Term Loans & Advances	600	441	294	178	101
Currents Investments	---	476	704	510	---
Short Term Loans and Advances	1,523	873	720	400	820
Total Current Assets	13,973	13,182	13,456	11,630	10,282
Total Assets	34,817	29,024	25,821	22,440	20,399
Adjusted Book Value	234	219	194	172	53,647

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 44.99, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 25.3%, indicating sustained price appreciation.
The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹3790 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹18194 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 921475

No. of Shares: 1111 (Approx)

Performance:-7.9%

-78525

NIFTY Performance: -6.2%

1 day Top Gainers